Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this appears to be a minor site version update with no visible changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page shows a revision metadata update from v3.4.0 to v3.4.1 with no changes to study details or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedAdded a glossary toggle; updated footer metadata with Last Update Submitted that Met QC Criteria and Last Update Posted, adjusted No FEAR Act wording/case, and upgraded Revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check39 days agoChange DetectedA new page revision label (v3.3.4) appears, replacing the previous revision (v3.3.3).SummaryDifference0.1%

- Check60 days agoChange DetectedThe additions and deletions appear to be timestamp updates for the page rather than changes to core study content (e.g., eligibility, arms, outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check68 days agoChange DetectedAdded a dedicated Locations section with Florida as a study site, replacing the previous Florida Locations label; the page revision is shown as v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.